LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinomaRongqi Sun, Jian Zhou, Chu‐Bin Luo et al.|Hepatology|2024Cited by 5
Association of <i>IDH1</i> mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapyShaolai Zhou, Yuhang Ye, Zhiqiang Hu et al.|The Oncologist|2026Cited by 0